Name | Title | Contact Details |
---|
OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. have entered a global collaboration and licensing agreement to develop and commercialize OncoGenex' lead drug candidate, custirsen. Custirsen is currently in Phase 3 clinical development as a treatment in men with metastatic castrate-resistant prostate cancer and in patients with advanced, unresectable non-small cell lung cancer. Apatorsen is in Phase 2 clinical development and OGX-225 is currently in pre-clinical development.
Momentum Healthware Inc. is a Winnipeg, MB-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Healthcare Integrated Technologies, Inc. is focused on developing effective, non-intrusive, resident monitoring technologies for senior living communities. Healthcare Integrated Technologies is headquartered in Knoxville, Tennessee.
Cary HealthCare L L C is a Cary, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Gordian Health Solutions is a Franklin, TN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.